{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:51:02Z","timestamp":1788367862332,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1I1A3074384"],"award-info":[{"award-number":["NRF-2020R1I1A3074384"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1A5A2017323"],"award-info":[{"award-number":["NRF-2020R1A5A2017323"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s12272-022-01407-0","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T07:02:57Z","timestamp":1664521377000},"page":"743-760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Enhanced bioavailability and hepatoprotective effect of silymarin by preparing silymarin-loaded solid dispersion formulation using freeze-drying method"],"prefix":"10.1007","volume":"45","author":[{"given":"Dong Yu","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyeong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehyeok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hyeon","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hyang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Koo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4564-709X","authenticated-orcid":false,"given":"Im-Sook","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"1407_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrgentox.2015.08.006","volume":"792","author":"M Adhikari","year":"2015","unstructured":"Adhikari M, Arora R (2015) Nano-silymarin provides protection against \u03b3-radiation-induced oxidative stress in cultured human embryonic kidney cells. Mutat Res Genet Toxicol Environ Mutagen 792:1\u201311. https:\/\/doi.org\/10.1016\/j.mrgentox.2015.08.006","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"1407_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/(SICI)1099-0844(199703)15:1<27::AID-CBF714>3.0.CO;2-W","volume":"15","author":"H Basaga","year":"1997","unstructured":"Basaga H, Poli G, Tekkaya C, Aras I (1997) Free radical scavenging and antioxidative properties of \u201csilibin\u201d complexes on microsomal lipid peroxidation. Cell Biochem Funct 15:27\u201333. https:\/\/doi.org\/10.1002\/(SICI)1099-0844(199703)15:1%3c27::AID-CBF714%3e3.0.CO;2-W","journal-title":"Cell Biochem Funct"},{"key":"1407_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4155\/tde-2019-0007","volume":"10","author":"AG Cid","year":"2019","unstructured":"Cid AG, Simonazzi A, Palma SD, Berm\u00fadez JM (2019) Solid dispersion technology as a strategy to improve the bioavailability of poorly soluble drugs. Ther Deliv 10:363\u2013382. https:\/\/doi.org\/10.4155\/tde-2019-0007","journal-title":"Ther Deliv"},{"key":"1407_CR4","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s11095-007-9492-0","volume":"25","author":"JW Deng","year":"2008","unstructured":"Deng JW, Shon JH, Shin HJ, Park SJ, Yeo CW, Zhou HH, Song IS, Shin JG (2008) Effect of silymarin supplement on the pharmacokinetics of rosuvastatin. Pharm Res 25:1807\u20131814. https:\/\/doi.org\/10.1007\/s11095-007-9492-0","journal-title":"Pharm Res"},{"key":"1407_CR5","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3390\/molecules24112155","volume":"24","author":"A Di Costanzo","year":"2019","unstructured":"Di Costanzo A, Angelico R (2019) Formulation strategies for enhancing the bioavailability of silymarin: the state of the art. Molecules 24:2155. https:\/\/doi.org\/10.3390\/molecules24112155","journal-title":"Molecules"},{"key":"1407_CR6","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1021\/acs.molpharmaceut.6b00851","volume":"14","author":"D Dong","year":"2017","unstructured":"Dong D, Quan E, Yuan X, Xie Q, Li Z, Wu B (2017) Sodium oleate-based nanoemulsion enhances oral absorption of chrysin through inhibition of UGT-mediated metabolism. Mol Pharm 14:2864\u20132874. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00851","journal-title":"Mol Pharm"},{"key":"1407_CR7","doi-asserted-by":"publisher","first-page":"11118","DOI":"10.1038\/s41598-019-47250-0","volume":"9","author":"M Fenclova","year":"2019","unstructured":"Fenclova M, Novakova A, Viktorova J, Jonatova P, Dzuman Z, Ruml T, Kren V, Hajslova J, Vitek L, Stranska-Zachariasova M (2019) Poor chemical and microbiological quality of the commercial milk thistle-based dietary supplements may account for their reported unsatisfactory and non-reproducible clinical outcomes. Sci Rep 9:11118. https:\/\/doi.org\/10.1038\/s41598-019-47250-0","journal-title":"Sci Rep"},{"key":"1407_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jconrel.2017.01.014","volume":"248","author":"R Ghadi","year":"2017","unstructured":"Ghadi R, Dand N (2017) BCS class IV drugs: highly notorious candidates for formulation development. J Control Release 248:71\u201395. https:\/\/doi.org\/10.1016\/j.jconrel.2017.01.014","journal-title":"J Control Release"},{"key":"1407_CR9","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1080\/00498254.2021.1963503","volume":"51","author":"SN Jang","year":"2021","unstructured":"Jang SN, Park SY, Lee H, Jeong H, Jeon JH, Song IS, Kwon MJ, Liu KH (2021) In vitro modulatory effects of ginsenoside compound K, 20(S)-protopanaxadiol and 20(S)-protopanaxatriol on uridine 5\u2032-diphospho-glucuronosyltransferase activity and expression. Xenobiotica 51:1087\u20131094. https:\/\/doi.org\/10.1080\/00498254.2021.1963503","journal-title":"Xenobiotica"},{"key":"1407_CR10","first-page":"239","volume":"16","author":"S Javed","year":"2011","unstructured":"Javed S, Kohli K, Ali M (2011) Reassessing bioavailability of silymarin. Altern Med Rev 16:239\u2013249","journal-title":"Altern Med Rev"},{"key":"1407_CR11","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s12272-020-01289-0","volume":"43","author":"JH Jeon","year":"2020","unstructured":"Jeon JH, Lee J, Choi MK, Song IS (2020) Pharmacokinetics of ginsenosides following repeated oral administration of red ginseng extract significantly differ between species of experimental animals. Arch Pharm Res 43:1335\u20131346. https:\/\/doi.org\/10.1007\/s12272-020-01289-0","journal-title":"Arch Pharm Res"},{"key":"1407_CR12","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1007\/s12272-020-01292-5","volume":"43","author":"YH Ko","year":"2020","unstructured":"Ko YH, Kim SK, Lee SY, Jang CG (2020) Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression. Arch Pharm Res 43:1128\u20131143. https:\/\/doi.org\/10.1007\/s12272-020-01292-5","journal-title":"Arch Pharm Res"},{"key":"1407_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1615\/critrevtherdrugcarriersyst.2013005964","volume":"30","author":"S Kumar","year":"2013","unstructured":"Kumar S, Bhargava D, Thakkar A, Arora S (2013) Drug carrier systems for solubility enhancement of BCS Class II Drugs: a critical review. Crit Rev Ther Drug Carrier Syst 30:217\u2013256. https:\/\/doi.org\/10.1615\/critrevtherdrugcarriersyst.2013005964","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"1407_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.dmpk.2017.05.005","volume":"32","author":"M Kwon","year":"2017","unstructured":"Kwon M, Ji HK, Goo SH, Nam SJ, Kang YJ, Lee E, Liu KH, Choi MK, Song IS (2017) Involvement of intestinal efflux and metabolic instability in the pharmacokinetics of platycodin D in rats. Drug Metab Pharmacokinet 32:248\u2013254. https:\/\/doi.org\/10.1016\/j.dmpk.2017.05.005","journal-title":"Drug Metab Pharmacokinet"},{"key":"1407_CR15","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3390\/pharmaceutics12090882","volume":"12","author":"M Kwon","year":"2020","unstructured":"Kwon M, Lim DY, Lee CH, Jeon JH, Choi MK, Song IS (2020) Enhanced intestinal absorption and pharmacokinetic modulation of berberine and its metabolites through the inhibition of P-glycoprotein and intestinal netabolism in rats using a berberine mixed micelle formulation. Pharmaceutics 12:882. https:\/\/doi.org\/10.3390\/pharmaceutics12090882","journal-title":"Pharmaceutics"},{"key":"1407_CR16","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1124\/dmd.119.087965","volume":"47","author":"H Lee","year":"2019","unstructured":"Lee H, Heo JK, Lee GH, Park SY, Jang SN, Kim HJ, Kwon MJ, Song IS, Liu KH (2019) Ginsenoside Rc is a new selective UGT1A9 inhibitor in human liver microsomes and recombinant human UGT isoforms. Drug Metab Dispos 47:1372. https:\/\/doi.org\/10.1124\/dmd.119.087965","journal-title":"Drug Metab Dispos"},{"key":"1407_CR17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1208\/s12249-010-9432-x","volume":"11","author":"X Li","year":"2010","unstructured":"Li X, Yuan Q, Huang Y, Zhou Y, Liu Y (2010) Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailability. AAPS Pharm Sci Tech 11:672\u2013678. https:\/\/doi.org\/10.1208\/s12249-010-9432-x","journal-title":"AAPS Pharm Sci Tech"},{"key":"1407_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF03188811","volume":"18","author":"P Morazzoni","year":"1993","unstructured":"Morazzoni P, Montalbetti A, Malandrino S, Pifferi G (1993) Comparative pharmacokinetics of silipide and silymarin in rats. Eur J Drug Metab Pharmacokinet 18:289\u2013297. https:\/\/doi.org\/10.1007\/BF03188811","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"1407_CR19","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/jps.21836","volume":"99","author":"DR Mudra","year":"2010","unstructured":"Mudra DR, Borchardt RT (2010) Absorption barriers in the rat intestinal mucosa. 3: effects of polyethoxylated solubilizing agents on drug permeation and metabolism. J Pharm Sci 99:1016\u20131027. https:\/\/doi.org\/10.1002\/jps.21836","journal-title":"J Pharm Sci"},{"key":"1407_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0378-5173(00)00559-7","volume":"209","author":"ES Park","year":"2000","unstructured":"Park ES, Chang SY, Hahn M, Chi SC (2000) Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen. Int J Pharm 209:109\u2013119. https:\/\/doi.org\/10.1016\/S0378-5173(00)00559-7","journal-title":"Int J Pharm"},{"key":"1407_CR21","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/pharmaceutics12111036","volume":"12","author":"EJ Park","year":"2020","unstructured":"Park EJ, Park R, Jeon JH, Cho YY, Lee JY, Kang HC, Song IS, Lee HS (2020) Inhibitory effect of AB-PINACA, indazole carboxamide synthetic cannabinoid, on human major drug-metabolizing enzymes and transporters. Pharmaceutics 12:1036. https:\/\/doi.org\/10.3390\/pharmaceutics12111036","journal-title":"Pharmaceutics"},{"key":"1407_CR22","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.3390\/ijms20071606","volume":"20","author":"A P\u00e9rez-S\u00e1nchez","year":"2019","unstructured":"P\u00e9rez-S\u00e1nchez A, Cuy\u00e0s E, Ruiz-Torres V, Agull\u00f3-Chazarra L, Verdura S, Gonz\u00e1lez-lvarez I, Bermejo M, Joven J, Micol V, Bosch-Barrera J, Menendez JA (2019) Intestinal permeability study of clinically relevant formulations of silibinin in Caco-2 cell monolayers. Int J Mol Sci 20:1606. https:\/\/doi.org\/10.3390\/ijms20071606","journal-title":"Int J Mol Sci"},{"key":"1407_CR23","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1073\/pnas.0914009107","volume":"107","author":"SJ Polyak","year":"2010","unstructured":"Polyak SJ, Morishima C, Lohmann V, Pal S, Lee DY, Liu Y, Graf TN, Oberlies NH (2010) Identification of hepatoprotective flavonolignans from silymarin. Proc Natl Acad Sci USA 107:5995\u20135999. https:\/\/doi.org\/10.1073\/pnas.0914009107","journal-title":"Proc Natl Acad Sci USA"},{"key":"1407_CR24","doi-asserted-by":"publisher","first-page":"8601","DOI":"10.3390\/molecules16108601","volume":"16","author":"A Raskovic","year":"2011","unstructured":"Raskovic A, Stilinovic N, Kolarovic J, Vasovic V, Vukmirovic S, Mikov M (2011) The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats. Molecules 16:8601\u20138613. https:\/\/doi.org\/10.3390\/molecules16108601","journal-title":"Molecules"},{"key":"1407_CR25","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2147\/Dddt.S133806","volume":"11","author":"MUK Sahibzada","year":"2017","unstructured":"Sahibzada MUK, Sadiq A, Khan S, Faidah HS, Khurram M, Amin MU, Haseeb A (2017) Fabrication, characterization and in vitro evaluation of silibinin nanoparticles: an attempt to enhance its oral bioavailability. Drug Des Dev Ther 11:1453\u20131464. https:\/\/doi.org\/10.2147\/Dddt.S133806","journal-title":"Drug Des Dev Ther"},{"key":"1407_CR26","first-page":"61","volume":"45","author":"HU Schulz","year":"1995","unstructured":"Schulz HU, Schurer M, Krumbiegel G, Wachter W, Weyhenmeyer R, Seidel G (1995) The solubility and bioequivalence of silymarin preparations. Arzneimittelforschung 45:61\u201364","journal-title":"Arzneimittelforschung"},{"key":"1407_CR27","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1089\/15230860260220166","volume":"4","author":"RP Singh","year":"2002","unstructured":"Singh RP, Agarwal R (2002) Flavonoid antioxidant silymarin and skin cancer. Antioxid Redox Signal 4:655\u2013663. https:\/\/doi.org\/10.1089\/15230860260220166","journal-title":"Antioxid Redox Signal"},{"key":"1407_CR28","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/pharmaceutics13050628","volume":"13","author":"IS Song","year":"2021","unstructured":"Song IS, Nam SJ, Jeon JH, Park SJ, Choi MK (2021) Enhanced bioavailability and efficacy of silymarin solid dispersion in rats with acetaminophen-induced hepatotoxicity. Pharmaceutics 13:628. https:\/\/doi.org\/10.3390\/pharmaceutics13050628","journal-title":"Pharmaceutics"},{"key":"1407_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/pharmaceutics11030132","volume":"11","author":"P Tran","year":"2019","unstructured":"Tran P, Pyo YC, Kim DH, Lee SE, Kim JK, Park JS (2019) Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs. Pharmaceutics 11:132. https:\/\/doi.org\/10.3390\/pharmaceutics11030132","journal-title":"Pharmaceutics"},{"key":"1407_CR30","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1002\/med.21791","volume":"41","author":"V Tvrd\u00fd","year":"2021","unstructured":"Tvrd\u00fd V, Pourov\u00e1 J, Jirkovsk\u00fd E, K\u0159en V, Valentov\u00e1 K, Mlad\u011bnka P (2021) Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin. Med Res Rev 41:2195\u20132246. https:\/\/doi.org\/10.1002\/med.21791","journal-title":"Med Res Rev"},{"key":"1407_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1124\/dmd.107.017566","volume":"36","author":"Z Wen","year":"2008","unstructured":"Wen Z, Dumas TE, Schrieber SJ, Hawke RL, Fried MW, Smith PC (2008) Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. Drug Metab Dispos 36:65\u201372. https:\/\/doi.org\/10.1124\/dmd.107.017566","journal-title":"Drug Metab Dispos"},{"key":"1407_CR32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jpba.2007.06.026","volume":"45","author":"JW Wu","year":"2007","unstructured":"Wu JW, Lin LC, Hung SC, Chi CW, Tsai TH (2007) Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application. J Pharm Biomed Anal 45:635\u2013641. https:\/\/doi.org\/10.1016\/j.jpba.2007.06.026","journal-title":"J Pharm Biomed Anal"},{"key":"1407_CR33","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.3390\/Molecules24203693","volume":"24","author":"Y Xie","year":"2019","unstructured":"Xie Y, Zhang DQ, Zhang J, Yuan JL (2019) Metabolism, transport and drug-drug interactions of silymarin. Molecules 24:3693. https:\/\/doi.org\/10.3390\/Molecules24203693","journal-title":"Molecules"},{"key":"1407_CR34","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.2147\/ijn.s50683","volume":"8","author":"KY Yang","year":"2013","unstructured":"Yang KY, Du Hwang H, Yousaf AM, Kim DW, Shin YJ, Bae ON, Kim YI, Kim JO, Yong CS, Choi HG (2013) Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation. Int J Nanomed 8:3333\u20133343. https:\/\/doi.org\/10.2147\/ijn.s50683","journal-title":"Int J Nanomed"},{"key":"1407_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpha.2018.09.003","volume":"9","author":"AM Yousaf","year":"2019","unstructured":"Yousaf AM, Malik UR, Shahzad Y, Mahmood T, Hussain T (2019) Silymarin-laden PVP-PEG polymeric composite for enhanced aqueous solubility and dissolution rate: preparation and in vitro characterization. J Pharm Anal 9:34\u201339. https:\/\/doi.org\/10.1016\/j.jpha.2018.09.003","journal-title":"J Pharm Anal"},{"key":"1407_CR36","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/bf02976689","volume":"26","author":"H Zhang","year":"2003","unstructured":"Zhang H, Yao M, Morrison RA, Chong S (2003) Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats. Arch Pharm Res 26:768\u2013772. https:\/\/doi.org\/10.1007\/bf02976689","journal-title":"Arch Pharm Res"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-022-01407-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-022-01407-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-022-01407-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T17:47:09Z","timestamp":1667843229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12272-022-01407-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1407"],"URL":"https:\/\/doi.org\/10.1007\/s12272-022-01407-0","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"22 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}